Data from the US ReActiv8 B trial of Mainstay Medical International PLC's ReActiv8 neurostimulator to treat low-back pain will supplement the company's regulatory application in Australia.
The Irish company announced on April 5 that Australia's Therapeutic Goods Administration has requested additional clinical data supporting the regulatory...







